Biosynthesis of tetrahydropapaverine and semisynthesis of papaverine in yeast.
Biosynthesis of tetrahydropapaverine and semisynthesis of papaverine in yeast.
复制标题
DOI:
10.1073/pnas.2205848119
复制
发表时间:
2022-08-16
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
We report the de novo microbial biosynthesis of (S)-tetrahydropapaverine (THP) and the semisynthesis of papaverine using microbially biosynthesized THP. We used protein engineering to develop variants of two enzymes with improved nonnative activity on pathway intermediates. The biosynthesis of THP demonstrates the ability to use protein homologs and protein engineering to replace the activity of unknown enzymes in heterologous biosynthetic pathways. We improved pathway flux by knocking out two yeast multidrug resistance (MDR) transporters, which reduces the export of pathway intermediates. MDR knockouts may be applied to increase flux through other heterologous pathways. The strain engineering in this work provides a demonstration of fermentation-based production of the clinically significant molecules THP and papaverine, which have experienced recent supply chain shortages. Tetrahydropapaverine (THP) and papaverine are plant natural products with clinically significant roles. THP is a precursor in the production of the drugs atracurium and cisatracurium, and papaverine is used as an antispasmodic during vascular surgery. In recent years, metabolic engineering advances have enabled the production of natural products through heterologous expression of pathway enzymes in yeast. Heterologous biosynthesis of THP and papaverine could play a role in ensuring a stable supply of these clinically significant products. Biosynthesis of THP and papaverine has not been achieved to date, in part because multiple pathway enzymes have not been elucidated. Here, we describe the development of an engineered yeast strain for de novo biosynthesis of THP. The production of THP is achieved through heterologous expression of two enzyme variants with activity on nonnative substrates. Through protein engineering, we developed a variant of N-methylcoclaurine hydroxylase with activity on coclaurine, enabling de novo norreticuline biosynthesis. Similarly, we developed a variant of scoulerine 9-O-methyltransferase capable of O-methylating 1-benzylisoquinoline alkaloids at the 3′ position, enabling de novo THP biosynthesis. Flux through the heterologous pathway was improved by knocking out yeast multidrug resistance transporters and optimization of media conditions. Overall, strain engineering increased the concentration of biosynthesized THP 600-fold to 121 µg/L. Finally, we demonstrate a strategy for papaverine semisynthesis using hydrogen peroxide as an oxidizing agent. Through optimizing pH, temperature, reaction time, and oxidizing agent concentration, we demonstrated the ability to produce semisynthesized papaverine through oxidation of biosynthesized THP.
登录
查看更多内容
影响因子:
4.8
作者:
Hagel, Jillian M.;Beaudoin, Guillaume A. W.;Facchini, Peter J.
通讯作者:
Facchini, Peter J.
影响因子:
48
作者:
Gibson, Daniel G.;Young, Lei;Smith, Hamilton O.
通讯作者:
Smith, Hamilton O.
影响因子:
2.5
作者:
FUKUDA, K;WATANABE, M;TAKASAWA, S
通讯作者:
TAKASAWA, S
影响因子:
3.8
作者:
Han, Xu;Lamshoeft, Marc;Zenk, Meinhart H.
通讯作者:
Zenk, Meinhart H.
影响因子:
16.6
作者:
Harris A;Wagner M;Du D;Raschka S;Nentwig LM;Gohlke H;Smits SHJ;Luisi BF;Schmitt L
通讯作者:
Schmitt L